Les médicaments génériques et l’évolution de la consommation des antihypertenseurs au Maroc

Azizi, G. Berrada El; Ahid, Samir; Ghannam, Imane; Belaiche, A.; Hassar, Mohammed; Cherrah, Yahia

doi:10.2515/therapie/2013048

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Morocco, the use of antihypertensive drugs increased from 0.08 to 10.65 DDD/1000 inhabitants/day between 1991 and 2010 with a dominance of CCB drugs (82.09%) followed by ACEI drugs (48.29%). 18 …”

Section: Discussionmentioning

confidence: 99%

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study

Elyamani

Soulaymani

Serhier

et al. 2020

African Journal of Primary Health Care & Family Medicine

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study

Elyamani

Soulaymani

Serhier

et al. 2020

African Journal of Primary Health Care & Family Medicine

View full text Add to dashboard Cite

Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries

Bruyn

Nguyen

Schutte

et al. 2022

View full text Add to dashboard Cite

Objective:The World Health Organization (WHO) included single-pill combination (SPC) antihypertensive medications on their 2019 essential medicines list (EML) to encourage uptake and improved hypertension control. We documented key nationallevel facilitators (SPCs on national EMLs, recommendation for SPCs in national hypertension guidelines and availability of SPCs on the market) supporting uptake of SPCs in the 30 most populous low-and middle-income countries (LMICs).Methods: A hierarchical information gathering strategy was used including literature and web searches, the use of organisational databases and personal communications with colleagues to obtain information on (1) whether SPC antihypertensives are on national EMLs, (2) whether SPC antihypertensives are recommended in national hypertension guidelines and (3) whether SPCs are available on the market.Results: Eleven of 30 LMICs had all facilitators in place being Egypt,

show abstract

Les médicaments génériques et l’évolution de la consommation des antihypertenseurs au Maroc

Cited by 2 publications

References 32 publications

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study

Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries

Contact Info

Product

Resources

About